Northwestern Mutual Wealth Management’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5
Closed -$255 3710
2024
Q1
$255 Buy
+5
New +$167 ﹤0.01% 3378
2020
Q2
Sell
-4
Closed -$1K 2573
2020
Q1
$1K Buy
+4
New +$823 ﹤0.01% 2427

Other funds holding NGNE

Northwestern Mutual Wealth Management's NGNE Position: Q2 2024 in Review

Northwestern Mutual Wealth Management sold out of Neurogene (NGNE) in Q2 2024, closing a stake of 5 shares — an estimated $255 sold.

Northwestern Mutual Wealth Management first reported a position in NGNE in Q1 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2020. 66 funds tracked by Wall St. Rank hold NGNE as of Q2 2024.

  • Northwestern Mutual Wealth Management reported no remaining Neurogene position as of Q2 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 5 Neurogene shares in Q2 2024, an estimated $255.
  • Northwestern Mutual Wealth Management first reported a position in Neurogene in Q1 2020 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Neurogene position peaked at $1K in Q1 2020.
  • 66 funds tracked by Wall St. Rank held Neurogene as of Q2 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2024, filed 16 Aug 2024.